Elaine J. Heron - 03 Jun 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
03 Jun 2024
Net transactions value
-$11.18
Form type
4
Filing time
04 Jun 2024, 19:29:46 UTC
Previous filing
23 May 2024
Next filing
12 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $318,466 +5,047 +5.2% $63.10 101,888 03 Jun 2024 Direct
transaction BMRN Common Stock Tax liability $318,477 -4,168 -4.1% $76.41 97,720 03 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -5,047 -100% $0.000000* 0 03 Jun 2024 Common Stock 5,047 $63.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.